1. Home
  2. AIMD vs ONFO Comparison

AIMD vs ONFO Comparison

Compare AIMD & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ONFO
  • Stock Information
  • Founded
  • AIMD 1984
  • ONFO 2018
  • Country
  • AIMD United States
  • ONFO United States
  • Employees
  • AIMD N/A
  • ONFO N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ONFO Computer Software: Programming Data Processing
  • Sector
  • AIMD Health Care
  • ONFO Technology
  • Exchange
  • AIMD Nasdaq
  • ONFO Nasdaq
  • Market Cap
  • AIMD 8.2M
  • ONFO 6.7M
  • IPO Year
  • AIMD N/A
  • ONFO 2022
  • Fundamental
  • Price
  • AIMD $0.63
  • ONFO $1.26
  • Analyst Decision
  • AIMD
  • ONFO
  • Analyst Count
  • AIMD 0
  • ONFO 0
  • Target Price
  • AIMD N/A
  • ONFO N/A
  • AVG Volume (30 Days)
  • AIMD 1.4M
  • ONFO 158.2K
  • Earning Date
  • AIMD 03-07-2025
  • ONFO 11-15-2024
  • Dividend Yield
  • AIMD N/A
  • ONFO N/A
  • EPS Growth
  • AIMD N/A
  • ONFO N/A
  • EPS
  • AIMD N/A
  • ONFO N/A
  • Revenue
  • AIMD $40,633.00
  • ONFO $6,590,171.00
  • Revenue This Year
  • AIMD N/A
  • ONFO $133.59
  • Revenue Next Year
  • AIMD N/A
  • ONFO N/A
  • P/E Ratio
  • AIMD N/A
  • ONFO N/A
  • Revenue Growth
  • AIMD N/A
  • ONFO 29.25
  • 52 Week Low
  • AIMD $0.40
  • ONFO $0.39
  • 52 Week High
  • AIMD $3.10
  • ONFO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 54.51
  • ONFO 44.75
  • Support Level
  • AIMD $0.61
  • ONFO $1.15
  • Resistance Level
  • AIMD $0.77
  • ONFO $1.39
  • Average True Range (ATR)
  • AIMD 0.12
  • ONFO 0.09
  • MACD
  • AIMD 0.01
  • ONFO -0.01
  • Stochastic Oscillator
  • AIMD 34.07
  • ONFO 36.67

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.

Share on Social Networks: